Back to Journals » OncoTargets and Therapy » Volume 15

Hsa_circ_RNA_0011780 Represses the Proliferation and Metastasis of Non-Small Cell Lung Cancer by Decreasing FBXW7 via Targeting miR-544a [Retraction]

Authors Liu Y, Yang C, Cao C, Li Q, Jin X, Shi H

Received 15 November 2022

Accepted for publication 15 November 2022

Published 16 November 2022 Volume 2022:15 Pages 1385—1386

DOI https://doi.org/10.2147/OTT.S397666



Liu Y, Yang C, Cao C, Li Q, Jin X, Shi H. Onco Targets Ther. 2020;13:745–755.

At the authors request, the Editor and Publisher of OncoTargets and Therapy wish to retract the published article. The authors became aware of concerns which had been raised regarding image duplication and data fabrication within the article. Specifically,

  • Flow cytometry images in Figure 2D, H226, oe-NC and oe-Circ appear to have been duplicated with slight modifications to each.
  • Flow cytometry images in Figure 2D, A549, oe-NC and oe-Circ appear to have been duplicated with slight modifications to each.
  • Migration images in Figure 2E, panel H226, oe-Circ and panel A549, oe-Circ appear to have been duplicated with slight modifications to each.
  • Tumor images in Figure 3F appear to have been duplicated with the same images in Figure 4E from Liu et al, 2020 (DOI: 10.26355/eurrev_202003_20504).

The authors did not provide an explanation for the image duplication and were unable to provide any original data for their study. The Editor agreed with the authors retraction request.

Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.


This retraction relates to this paper


Creative Commons License © 2022 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.